Literature DB >> 8861825

Pharmacotherapy of opioids: present and future developments.

T F Meert1.   

Abstract

The clinically available opioids have different physicochemical properties, resulting in differences in clinical profile with regard to potency, onset, and duration of activity. However, they all have comparable side-effects after acute systemic application. Several approaches can be used to overcome these side-effects. The following approaches, with special emphasis on the perioperative use of the opioids, are discussed: (1) the use of alternative routes of administration, such as via the spine (epidurally and intrathecally); (2) optimization of opioid delivery by means of slow-release preparations, chronic infusions with indwelling catheters, and transdermal delivery systems; (3) use of additional agents to potentiate the analgesic properties of the opioids so that the dose of opioid can be reduced; and (4) searching for new analgesics on the basis of knowledge of the pain-transmission system and the different opioid receptors with their functional interactions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8861825     DOI: 10.1007/bf00449683

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  115 in total

1.  Epidural bupivacaine, sufentanil or the combination for post-thoracotomy pain.

Authors:  J Mourisse; M A Hasenbos; M J Gielen; J E Moll; G J Cromheecke
Journal:  Acta Anaesthesiol Scand       Date:  1992-01       Impact factor: 2.105

Review 2.  Drug delivery systems. 6. Transdermal drug delivery.

Authors:  V V Ranade
Journal:  J Clin Pharmacol       Date:  1991-05       Impact factor: 3.126

3.  Relationship between the pharmacokinetics and the analgesic and respiratory pharmacodynamics of epidural sufentanil.

Authors:  G Koren; A N Sandler; J Klein; W C Whiting; L C Lau; P Slavchenko; D Daley
Journal:  Clin Pharmacol Ther       Date:  1989-10       Impact factor: 6.875

4.  Prolongation of postoperative epidural sufentanil analgesia with epinephrine.

Authors:  C H Leicht; A J Kelleher; D E Robinson; S E Dickerson
Journal:  Anesth Analg       Date:  1990-03       Impact factor: 5.108

5.  Epidural sufentanil/bupivacaine combinations for analgesia during labor: effect of varying sufentanil doses.

Authors:  G H Phillips
Journal:  Anesthesiology       Date:  1987-11       Impact factor: 7.892

6.  Comparison of epidural sufentanil plus clonidine with sufentanil alone for postoperative pain relief.

Authors:  M Vercauteren; E Lauwers; T Meert; S De Hert; H Adriaensen
Journal:  Anaesthesia       Date:  1990-07       Impact factor: 6.955

7.  Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion model.

Authors:  G S Ling; D Paul; R Simantov; G W Pasternak
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

Review 8.  Sufentanil: clinical use as postoperative analgesic--epidural/intrathecal route.

Authors:  J A Grass
Journal:  J Pain Symptom Manage       Date:  1992-07       Impact factor: 3.612

9.  A study of the effect of the irreversible delta receptor antagonist [D-Ala2,Leu5,Cys6]-enkephalin on delta cx and delta ncx opioid binding sites in vitro and in vivo.

Authors:  R B Rothman; V Bykov; A E Jacobson; K C Rice; J E Long; W D Bowen
Journal:  Peptides       Date:  1992 Jul-Aug       Impact factor: 3.750

10.  Biochemical and behavioral studies on the interaction between mu- and kappa-opiate agonists in mice.

Authors:  S N Thorat; P L Reddy; H N Bhargava
Journal:  Brain Res       Date:  1993-07-02       Impact factor: 3.252

View more
  2 in total

1.  Comparison of two automated solid phase extractions for the detection of ten fentanyl analogs and metabolites in human urine using liquid chromatography tandem mass spectrometry.

Authors:  Rebecca L Shaner; Pearl Kaplan; Elizabeth I Hamelin; William A Bragg; Rudolph C Johnson
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-05-24       Impact factor: 3.205

2.  Synthesis and investigations of double-pharmacophore ligands for treatment of chronic and neuropathic pain.

Authors:  Ruben Vardanyan; Gokhale Vijay; Gary S Nichol; Lu Liu; Isuru Kumarasinghe; Peg Davis; Todd Vanderah; Frank Porreca; Josephine Lai; Victor J Hruby
Journal:  Bioorg Med Chem       Date:  2009-06-02       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.